ANTITUMOR THERAPEUTIC PREPARATIONS INCLUDING THE COMBINATION OF CARTILAGINOUS EXTRACT AND THAT OF ANTINEOPLASTIC AGENT PROVIDING HIGH EFFICIENCY AT LOW TOXIC SIDE EFFECTS Russian patent published in 2003 - IPC

Abstract RU 2195946 C2

FIELD: medicine, pharmacology. SUBSTANCE: the innovation is described to use a liquid cartilaginous extract containing the molecules of up to 500 kDa molecular weight as a preparation to protect a patient against toxic side effects as a result of antineoplastic agents injected. Cartilaginous extract could be used in the content of either pharmaceutical composition or therapeutic kit containing an antineoplastic agent. EFFECT: combined therapy provides higher efficiency of antitumor action due to decreased number of toxic side effects. 6 cl, 3 dwg, 4 tbl

Similar patents RU2195946C2

Title Year Author Number
SHARK CARTILAGE EXTRACTS SHOWING ANTIANGIOGENIC ACTIVITY AND INFLUENCING ON TUMOR REGRESSION, METHODS OF THEIR PREPARING 1995
  • Ehrik Djupon
  • Pol' Brazo
  • Kristina Zhjuno
RU2156132C2
SHARK CARTILAGE EXTRACT WITH ANTICOLLAGENOLYTIC, ANTI-INFLAMMATORY, ANTI-ANGIOGENIC AND ANTITUMOR EFFECT, METHOD OF PREPARING, METHODS OF USE AND COMPOSITIONS CONTAINING THEREOF 1996
  • Djupon Ehrik
  • Brazo Pol'
  • Zhjuno Kristina
  • Maes Daniel' Kh.
  • Marenus Kennet
RU2181292C2
SHARK CARTILAGE EXTRACTS, METHODS OF THEIR PREPARING AND USING 1995
  • Ehrik Djupon
  • Pol' Brazo
  • Kristina Zhjuno
  • Daniel' Kh. Mas
  • Kennet Marenus
RU2157695C2
PHARMACEUTICAL COMPOSITION ELICITING ANTITUMOR EFFECT WITH REDUCED ADVERSE EFFECTS AND CONTAINING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID 1998
  • Shumegi Balazh
RU2214238C2
PLATINUM NANOCOMPOUNDS AND METHODS OF APPLYING THEREOF 2010
  • Sengupta Shiladit'Ja
  • Paraskar Abkhiman'Ju
  • Soni Shivani
  • Sengupta Poulomi
  • Basu Sudipta
RU2538199C2
USE OF RAPAMYCIN DERIVATIVE 2011
  • Lane Khejdi
  • O`Rejlli Terens
  • Vud Dzhinetta Mardzhori
RU2483727C1
INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE 2006
  • Lane Khejdi
  • O'Rejlli Terens
  • Vud Dzhinetta Mardzhori
RU2445093C2
APPLICATION OF RAPAMYCIN DERIVATIVE 2013
  • Khejdi Lane
  • Terens O'Rejlli
  • Dzhinetta Mardzhori Vud
RU2659725C2
PHARMACEUTICAL COMPOSITION ELICITING IMPROVED ANTITUMOR EFFECT AND/OR REDUCED ADVERSE EFFECTS AND COMPRISING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID 1998
  • Shumegi Balazh
RU2254129C2
APPLICATION OF RAPAMYCIN DERIVATIVE 2013
  • Khejdi Lane
  • Terens O'Rejlli
  • Dzhinetta Mardzhori Vud
RU2665138C2

RU 2 195 946 C2

Authors

Djupon Ehrik

Dates

2003-01-10Published

1998-03-11Filed